Primary Site >> Colorectal Cancer

Gene >> VEGFC

  • 2000
  • 2001
  • 2002
  • 2003
  • 2004
  • 2005
  • 2006
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Vegf, Vegf-B, Vegf-C and their receptors KDR, FLT-1 and FLT-4 during the neoplastic progression of human colonic mucosa.
PMID: 10738243
Ref: Vascular endothelial growth factor-C (VEGF-C) expression in human colorectal cancer tissues.
PMID: 10970690
Ref: VEGF-A, VEGF-C, and VEGF-D in colorectal cancer progression.
PMID: 11687953
Ref: Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma.
PMID: 11914602
Ref: Expression of the vascular endothelial growth factor receptor-3 (VEGFR-3) and its ligand VEGF-C in human colorectal adenocarcinoma.
PMID: 12168824
Ref: Clinical significance of angiogenic factor expression at the deepest invasive site of advanced colorectal carcinoma.
PMID: 12457033
Ref: Immunodetection and molecular forms of plasma vascular endothelial growth factor-C.
PMID: 12527932
Ref: Quantification of vascular endothelial growth factor-C and its receptor-3 messenger RNA with real-time quantitative polymerase chain reaction as a predictor of lymph node metastasis in human colorectal cancer.
PMID: 12660643
Ref: c-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases.
PMID: 12684423
Ref: The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
PMID: 12754739
Ref: The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis.
PMID: 12782675
Ref: Lymphagenesis correlates with expression of vascular endothelial growth factor-C in colorectal cancer.
PMID: 12792749
Ref: Quantitative analysis of lymphangiogenic markers in human colorectal cancer.
PMID: 12851706
Ref: Expression analysis of vascular endothelial growth factors and their relationships to lymph node metastasis in human colorectal cancer.
PMID: 12866573
Ref: Vascular endothelial growth factors C and D and lymphangiogenesis in gastrointestinal tract malignancy.
PMID: 12888807
Ref: Correlation between vascular endothelial growth factor C expression and lymph node metastasis in T1 carcinoma of the colon and rectum.
PMID: 14513319
Ref: Expression of VEGF-C and VEGF-D at the invasive edge correlates with lymph node metastasis and prognosis of patients with colorectal carcinoma.
PMID: 14720324
Ref: Expression pattern of vascular endothelial growth factor-C in human colorectal normal mucosa and neoplastic mucosa.
PMID: 15086167
Ref: Regulation of vascular endothelial growth factor (VEGF)-C and VEGF-D expression by the organ microenvironment in human colon carcinoma.
PMID: 15196547
Ref: Expression of vascular endothelial growth factor-C and the relationship between lymphangiogenesis and lymphatic metastasis in colorectal cancer.
PMID: 15484296
Ref: Expression of vascular endothelial growth factor C and its correlation with lymph node metastasis in colorectal carcinoma.
PMID: 15791852
Ref: (86)Y-CHX-A''-Diethylenetriamine pentaacetic acid-bevacizumab
PMID: 21433411
Ref: (64)Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-p-isothiocyanatobenzyl-bevacizumab-IRDye 800CW
PMID: 23534080
Ref: The lymphangiogenic vascular endothelial growth factors VEGF-C and -D are ligands for the integrin alpha9beta1.
PMID: 15590642
Ref: Vascular endothelial growth factor C promotes lymph node metastasis in a rectal cancer orthotopic model.
PMID: 15674494
Ref: Clinical significance of nuclear morphometry at the invasive front of T1 colorectal cancer and relation to expression of VEGF-A and VEGF-C.
PMID: 16015039
Ref: Pre-operative plasma levels of vascular endothelial growth factor A, C and D in patients with colorectal cancer.
PMID: 16097569
Ref: [Correlation of lymphangiogenesis to progression of colorectal cancer].
PMID: 16219148
Ref: [Relationship of vascular endothelial growth factor-C and lymphangiogenesis with the development and prognosis of colon cancer].
PMID: 16299655
Ref: Impact of laparotomy and liver resection on the peritoneal concentrations of fibroblast growth factor 2, vascular endothelial growth factor and hepatocyte growth factor.
PMID: 16249905
Ref: Vascular endothelial growth factors and receptors in colorectal cancer: implications for anti-angiogenic therapy.
PMID: 16321517
Ref: Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.
PMID: 16474989
Ref: The relationship between MSI status and vessel density in colorectal carcinoma.
PMID: 16739879
Ref: Serum vascular endothelial growth factor-C and vascular endothelial growth factor level in patients with colorectal carcinoma and clinical significance.
PMID: 16961284
Ref: [Clinical significance of detection on lymphatic microvessel, lymphatic microvessel density and vascular endothelial growth factor-C in patients with colorectal carcinoma].
PMID: 17143789
Ref: Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer.
PMID: 17641542
Ref: Vascular endothelial growth factor-C (VEGF-C) is a more specific risk factor for lymph node metastasis than VEGF-D in submucosal colorectal cancer.
PMID: 17419234
Ref: Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis.
PMID: 17446709
Ref: Predictive value of vascular endothelial growth factor-C expression for local recurrence of rectal carcinoma.
PMID: 17487386
Ref: A novel in vitro model of lymphatic metastasis from colorectal cancer.
PMID: 17640671
Ref: Clinical impact of matrix metalloproteinase-7 mRNA expression in the invasive front and inner surface of tumor tissues in patients with colorectal cancer.
PMID: 17676380
Ref: [The role of immune system in colon metastasis. Lymphangiogenesis or lymphedema in cancer tissue].
PMID: 17679395
Ref: [The expression of vascular endothelial growth factor C, ETS-1, microvessal density, and microlymphaticdensity and their clinicopathologic in colorectal carcinoma].
PMID: 17706142
Ref: Correlations between cyclooxygenase-2 expression and angiogenic factors in primary tumors and liver metastases in colorectal cancer.
PMID: 17846040
Ref: Lymphatic vessel density, microvessel density and lymphangiogenic growth factor expression in colorectal cancer.
PMID: 17931169
Ref: Distributions of angiogenesis and lymphangiogenesis in gastrointestinal intramucosal tumors.
PMID: 18202892
Ref: Hypoxia-induced epithelial VEGF-C/VEGFR-3 upregulation in carcinoma cell lines.
PMID: 18292935
Ref: Vector-based RNA interference against vascular endothelial growth factor-C inhibits tumor lymphangiogenesis and growth of colorectal cancer in vivo in mice.
PMID: 18364118
Ref: Circulating lymphangiogenic growth factors in gastrointestinal solid tumors, could they be of any clinical significance?
PMID: 18461654
Ref: Modification of the primary tumor microenvironment by transforming growth factor alpha-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model.
PMID: 18583324
Ref: VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab.
PMID: 18636661
Ref: Effect of chemotherapeutic stress on induction of vascular endothelial growth factor family members and receptors in human colorectal cancer cells.
PMID: 18790786
Ref: Clinical significance of plasma level of vascular endothelial growth factor-C in patients with colorectal cancer.
PMID: 18923001
Ref: Sialyl Lewis X expression and lymphatic microvessel density in primary tumors of node-negative colorectal cancer patients predict disease recurrence.
PMID: 19308692
Ref: Association between EGF, TGF-beta1, VEGF gene polymorphism and colorectal cancer.
PMID: 19011936
Ref: Preoperative serum levels of serum VEGF-C is associated with distant metastasis in colorectal cancer patients.
PMID: 19084972
Ref: Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma.
PMID: 19253334
Ref: Expression of Tiam1 and VEGF-C correlates with lymphangiogenesis in human colorectal carcinoma.
PMID: 19276682
Ref: Vascular endothelial growth factor-C siRNA delivered via calcium carbonate nanoparticle effectively inhibits lymphangiogenesis and growth of colorectal cancer in vivo.
PMID: 19409048
Ref: Irinotecan and colorectal cancer: the role of p53, VEGF-C and alpha-B-crystallin expression.
PMID: 20012297
Ref: Role of the VEGF ligand to receptor ratio in the progression of mismatch repair-proficient colorectal cancer.
PMID: 20222950
Ref: Elevated IGFIR expression regulating VEGF and VEGF-C predicts lymph node metastasis in human colorectal cancer.
PMID: 20459642
Ref: [Expression and significance of RECK, metalloproteinase-9 and vascular endothelial growth factor-C in colorectal cancer].
PMID: 20878580
Ref: The relationship among acute-phase response proteins, cytokines and hormones in cachectic patients with colon cancer.
PMID: 20920199
Ref: Vascular endothelial growth factor-A and -C: expression and correlations with lymphatic metastasis and prognosis in colorectal cancer.
PMID: 20107934
Ref: Immunohistochemical analysis of vascular density and area in colorectal carcinoma using different markers and comparison with clinicopathologic prognostic factors.
PMID: 21222066
Ref: Metastasis-associated protein 1 induces VEGF-C and facilitates lymphangiogenesis in colorectal cancer.
PMID: 21448429
Ref: Roles of VEGF-C and Smad4 in the lymphangiogenesis, lymphatic metastasis, and prognosis in colon cancer.
PMID: 21786062
Ref: Comparison of lymphangiogenesis between primary colorectal cancer and corresponding liver metastases.
PMID: 22199337
Ref: Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer.
PMID: 22295309
Ref: Cellular signal transduction pathways by leptin in colorectal cancer tissue: preliminary results.
PMID: 22363883
Ref: The relationship among acute-phase responce proteins, cytokines, and hormones in various gastrointestinal cancer types patients with cachectic.
PMID: 21803781
Ref: Downregulation of VEGF-C expression in lung and colon cancer cells decelerates tumor growth and inhibits metastasis via multiple mechanisms.
PMID: 21804602
Ref: Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
PMID: 21823121
Ref: Correlations between SUVmax and expression of GLUT1 and growth factors inducing lymphangiogenesis.
PMID: 22444673
Ref: The extra domain A of fibronectin increases VEGF-C expression in colorectal carcinoma involving the PI3K/AKT signaling pathway.
PMID: 22496919
Ref: Negative regulation of cell motile and invasive activities by lysophosphatidic acid receptor-3 in colon cancer HCT116 cells.
PMID: 22763559
Ref: Clinical procedure for colon carcinoma tissue sampling directly affects the cancer marker-capacity of VEGF family members.
PMID: 23148666
Ref: Relationship between expression and prognostic ability of PTEN, STAT3 and VEGF-C in colorectal cancer.
PMID: 23170117
Ref: Tropomyosin receptor kinases B and C are tumor progressive and metastatic marker in colorectal carcinoma.
PMID: 23332094
Ref: Expression of GLI1 correlates with expression of lymphangiogenesis proteins, vascular endothelial growth factor C and vascular endothelial growth factor receptor 3, in colorectal cancer.
PMID: 23336661
Ref: miRNA-27b targets vascular endothelial growth factor C to inhibit tumor progression and angiogenesis in colorectal cancer.
PMID: 23593282
Ref: Clinicopathological correlation and prognostic significance of VEGF-A, VEGF-C, VEGFR-2 and VEGFR-3 expression in colorectal cancer.
PMID: 23603341
Ref: [Effect of vascular endothelial growth factor C and collagen triple helix repeat containing 1 expression on prognosis of rectal carcinoma patients].
PMID: 23888454
Ref: New molecular staging with G-factors (VEGF-C and Reg IV) by supplementing TNM classification in colorectal cancers.
PMID: 24101199
Ref: [Expression and clinical significance of vascular endothelial growth factor-C and nm23-H1 in stage II and III colorectal carcinomas].
PMID: 24119904
Ref: VEGF-C and VEGF-D overexpression is more common in left-sided and well-differentiated colon adenocarcinoma.
PMID: 24173916
Ref: Epithelial membrane protein 1 negatively regulates cell growth and metastasis in colorectal carcinoma.
PMID: 24744589
Ref: Effect of thoracic epidural anaesthesia on serum vascular endothelial growth factor C and cytokines in patients undergoing anaesthesia and surgery for colon cancer.
PMID: 24966150
Ref: Possible involvement of tumor-producing VEGF-A in the recruitment of lymphatic endothelial progenitor cells from bone marrow.
PMID: 25242215
Ref: MMP-11 and VEGF-C expression correlate with clinical features of colorectal adenocarcinoma.
PMID: 25356153
Ref: Metastasis-associated in colon cancer-1 upregulates vascular endothelial growth factor-C/D to promote lymphangiogenesis in human gastric cancer.
PMID: 25444928
Ref: Neuropilin-2 mediates lymphangiogenesis of colorectal carcinoma via a VEGFC/VEGFR3 independent signaling.
PMID: 25543087
Ref: Smad4 acts as tumor suppressor by antagonizing lymphangiogenesis in colorectal cancer.
PMID: 25680269
Ref: Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion.
PMID: 25754161
Ref: The relevance of cell type- and tumor zone-specific VEGFR-2 activation in locally advanced colon cancer.
PMID: 25967108
Ref: High-mobility group box 1 protein activating nuclear factor-kappaB to upregulate vascular endothelial growth factor C is involved in lymphangiogenesis and lymphatic node metastasis in colon cancer.
PMID: 26001393
Ref: Paracrine factors from adipose-mesenchymal stem cells enhance metastatic capacity through Wnt signaling pathway in a colon cancer cell co-culture model.
PMID: 26060426
Ref: Vascular endothelial growth factor D expression is a potential biomarker of bevacizumab benefit in colorectal cancer.
PMID: 26125443
Ref: MTA1 Is Up-regulated in Colorectal Cancer and Is Inversely Correlated with Lymphatic Metastasis.
PMID: 26543080
Ref: Impact of prospero homeobox-1 on tumor cell behavior and prognosis in colorectal cancer.
PMID: 26807311
Ref: VEGF-C expression is not a prognostic factor in locally advanced colon adenocarcinoma.
PMID: 26843840
Ref: Comparison of (18)F-fluorodeoxyglucose PET/CT findings with vascular endothelial growth factors and receptors in colorectal cancer.
PMID: 26476536
Ref: Impact of KITENIN on tumor angiogenesis and lymphangiogenesis in colorectal cancer.
PMID: 26496979
Ref: Integrin alpha4 Induces Lymphangiogenesis and Metastasis via Upregulation of VEGF-C in Human Colon Cancer.
PMID: 26917449
Ref: Novel anti-angiogenic therapeutic strategies in colorectal cancer.
PMID: 26938715
Ref: Effect of Recepteur d'Origine Nantais expression on chemosensitivity and tumor cell behavior in colorectal cancer.
PMID: 27035413
Ref: Angiogenesis genotyping and clinical outcome during regorafenib treatment in metastatic colorectal cancer patients.
PMID: 27117754
Ref: BRG1 targeting STAT3/VEGFC signaling regulates lymphangiogenesis in colorectal cancer.
PMID: 27145366
Ref: Prognostic significance of VEGF-C immunohistochemical expression in colorectal cancer: A meta-analysis.
PMID: 27155587
Ref: High expression of WISP1 in colon cancer is associated with apoptosis, invasion and poor prognosis.
PMID: 27409174
Ref: Metastasis-associated in colon cancer-1 in gastric cancer: Beyond metastasis.
PMID: 27547006
Ref: Pien Tze Huang suppresses VEGF-C-mediated lymphangiogenesis in colorectal cancer.
PMID: 27779683
Ref: Expression analysis and clinical significance of eIF4E, VEGF-C, E-cadherin and MMP-2 in colorectal adenocarcinoma.
PMID: 27907907
Ref: TBL1XR1 predicts isolated tumor cells and micrometastasis in patients with TNM stage I/II colorectal cancer.
PMID: 28127799
Ref: Immunotherapy for the treatment of colorectal tumors: focus on approved and in-clinical-trial monoclonal antibodies.
PMID: 28138221
Ref: Colorectal polypoid lesions and expression of vascular endothelial growth factor in a consecutive series of endoscopic and surgical patients.
PMID: 28347226
Ref: Smad4 Inhibits VEGF-A and VEGF-C Expressions via Enhancing Smad3 Phosphorylation in Colon Cancer.
PMID: 28445620
Ref: Next-generation sequencing reveals lymph node metastasis associated genetic markers in colorectal cancer.
PMID: 28672935
Ref: Lymphangiogenic Gene Expression Is Associated With Lymph Node Recurrence and Poor Prognosis After Partial Hepatectomy for Colorectal Liver Metastasis.
PMID: 28742689
Ref: miR-144 inhibits growth and metastasis of cervical cancer cells by targeting VEGFA and VEGFC.
PMID: 29387205
Ref: VEGF pathway-targeting drugs induce evasive adaptation by activation of neuropilin-1/cMet in colon cancer cells.
PMID: 29532881
Ref: VEGF-C in rectal cancer tissues promotes tumor invasion and metastasis.
PMID: 29552758
Ref: Prognostic Value of ACVRL1 Expression in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy With Bevacizumab: Results From the Triplet Plus Bevacizumab (TRIBE) Study.
PMID: 29636300
Ref: Association Between c-Met and Lymphangiogenic Factors in Patients With Colorectal Cancer.
PMID: 29742856
Ref: Association Between Hypoxia-Inducible Factor-2alpha (HIF-2alpha) Expression and Colorectal Cancer and Its Prognostic Role: a Systematic Analysis.
PMID: 30021192
Ref: Analyzing the molecular mechanism of the tissue specificity of gastrointestinal stromal tumors by using bioinformatics approaches.
PMID: 30358224